Results 251 to 260 of about 6,287,371 (315)

Valproic Acid and Famotidine Drug-Drug Interaction: Report of a Pediatric Case. [PDF]

Cureus
Kato M, Mannina L, O'Bryant S, Hart D, Mirajkar A.   +4 more
europepmc   +1 more source

Baseline Neuroinflammation Stratifies TSPO‐PET Response to Disease‐Modifying Therapy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch, Markus Matilainen, Giulia N. Baldrighi, Marjo Nylund, Maija Saraste, Laura Airas   +5 more
wiley   +1 more source

A Drug-Drug Interaction of Ainuovirine with Fluconazole in Healthy Adults and Dose Optimization Informed by Pharmacokinetics Modelling. [PDF]

Drug Des Devel Ther
Huang J, Lei Y, Cai W, Meng Y, Xiao L, Zhao Y, Lin W, He Y, Huang K, Li L.   +9 more
europepmc   +1 more source

Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration. Objectives This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.
Bing Wu, Jie‐Jie Li, Jing Jing, Jin‐Xi Lin, Xia Meng, Yong Jiang, Yong‐Jun Wang, Hong‐Qiu Gu   +7 more
wiley   +1 more source

Benchmarking drug-drug interaction prediction methods: a perspective of distribution changes. [PDF]

Bioinformatics
Shen Z, Zhou M, Zhang Y, Yao Q.
europepmc   +1 more source

Knowledge-graph-enhanced multi-scale modeling for drug-drug interaction prediction. [PDF]

Mol Ther Nucleic Acids
Chen J, Deng Q, Zhen P, Hu J, Wang Y, Peng J, You Z, Shang X, Zhang X, Wang T.   +9 more
europepmc   +1 more source

FSSM-DDI: Fusion State Space Model for predicting drug-drug interaction using social-media and drug descriptions. [PDF]

BMC Biol
Zhang S, Zhang T, Wang D, Zhang X.
europepmc   +1 more source

Limitations of Subgroup Safety Analyses for Drug-Drug Interaction Evaluation: Insights from the Talazoparib P-gp Inhibitor Case. [PDF]

J Clin Pharmacol
Wang D, Nanavati C, Yang DZ, DeAnnuntis L, Elmeliegy M.   +4 more
europepmc   +1 more source

Safety and Drug-Drug Interaction Burden of Direct-Acting Antiviral Therapy for Hepatitis C: A Single-Center Community Hospital Analysis. [PDF]

Int J Hepatol
Okabe S, Doi A, Matsumoto K, Yamamoto M, Fukui K, Nishida T.   +5 more
europepmc   +1 more source

Teaching artificial intelligence through drug-drug interaction clustering analysis: Integrating project-based learning and large language models. [PDF]

PLoS Comput Biol
Lv J, Liu G, Zhou C.
europepmc   +1 more source